Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer

Abstract

Patients with IBD with a history of cancer are at increased risk of developing any (new or recurrent) cancer, with a predominant incidence of new cancers. Treatment with immunosuppressants has no overall major impact per se on this risk.